Microstad

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Microstad

What is Microstad? (Overview)

Microstad is a combination medication classified as a Combined Oral Contraceptive (COC). It is a highly effective, synthetic hormonal preparation taken by mouth for the singular purpose of preventing pregnancy in women of reproductive potential.

Property Description
Active ingredient Ethinyl Estradiol and Levonorgestrel
Form Oral Tablets
Pharmacological class Estrogen and Progestin Combination
Common use Pregnancy Prevention (Contraception)
Origin Synthetic Hormonal Derivative

Classification and Therapeutic Purpose

Microstad is defined by its composition as a combination of two synthetic sex hormones: an estrogen (Ethinyl Estradiol) and a progestin (Levonorgestrel). This places it within the established pharmaceutical category of Combined Oral Contraceptives. The combination is clinically recognized for achieving high contraceptive efficacy when used as directed. Consequently, the drug's intended role is to reliably stop conception.

The use of Levonorgestrel—a second-generation progestin—in combination with Ethinyl Estradiol is an established benchmark formulation for oral contraception. Its primary role is to establish controlled hormonal conditions that safeguard against unintended pregnancy.


Composition and Synthetic Nature

The active components, Ethinyl Estradiol and Levonorgestrel, are both synthetic derivatives that mimic the action of natural female hormones but are formulated for oral delivery and enhanced stability. The medication comes in the form of oral tablets, confirming its nature as a combination drug.

While Microstad is a specific trade name, the Ethinyl Estradiol and Levonorgestrel formulation is the basis for many equivalent, widely used contraceptives globally. This combination is highly effective primarily because the combined hormones suppress the natural signals from the brain, preventing the ovaries from releasing an egg (ovulation inhibition), and also thicken the cervical mucus to block sperm. This confirms the core function is achieved through systemic hormonal control rather than a local or barrier method.

What side effects are possible with Microstad?

Possible Side Effects and Safety Information

Microstad (Micronized Progesterone) is generally well-tolerated, but like all medications, it can cause side effects. These often depend on the dose and route of administration, with oral forms potentially leading to more systemic effects.


Common Side Effects

Side effects that are frequently reported include dizziness and drowsiness, which is why oral administration is often recommended at bedtime. Other common effects are:

  • Gastrointestinal issues: Nausea, vomiting, diarrhea, constipation, abdominal cramping, and bloating.
  • Hormonal effects: Breast tenderness or pain, irregular vaginal bleeding or spotting, and vaginal discharge.
  • Central Nervous System (CNS) effects: Headache, fatigue, and mood changes (e.g., anxiety, depression, irritability).

Serious Side Effects and Warnings

Although rare, serious side effects can occur, which require immediate medical attention. The use of progesterone, particularly in combination with estrogen, has been associated with an increased risk of thromboembolic events, such as deep vein thrombosis (DVT), pulmonary embolism (PE), stroke, and heart attack. Signs of these conditions include:

  • Sudden, severe headache or slurred speech.
  • Sudden chest pain, shortness of breath, or coughing up blood.
  • Pain, swelling, or warmth in the leg (especially the calf).
  • Sudden vision changes or loss of vision.

Microstad should not be used in patients with a history of blood clots, certain cancers (like breast cancer), or liver dysfunction. Caution is advised for patients with conditions that may be worsened by fluid retention, such as asthma or migraines. If any serious or persistent side effects occur, consult a healthcare professional immediately.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documentation for Microstad (Ethinyl Estradiol and Levonorgestrel) defines the potential for overdose based on documented clinical experience and requires specific emergency actions.


Documented Overdose Presentation

Acute ingestion of large doses of this combined oral contraceptive has not been associated with reports of serious adverse effects. The manifestations that are officially documented following overdose are typically mild and may include Nausea and Vomiting. In females, Withdrawal Bleeding (vaginal bleeding) is also listed as a potential presentation. A specific consideration noted in official documents is that the acute ingestion of large doses by young children has likewise been documented as not resulting in serious adverse effects.


Emergency Actions and Management

Immediate medical assistance must be sought for any suspected overdose. Contact a poison control center or emergency room at once as mandated by regulatory guidance.

The official overdose profile is constrained by the fact that no specific antidote is known for this medication. Therefore, management relies entirely on providing symptomatic treatment and supportive treatment as required to address the clinical manifestations. Observation in a medical setting may be required to monitor the patient's condition and ensure stability.

Therapeutic Uses of Microstad

What Microstad Treats: Main Uses and Benefits

Microstad (Ethinyl Estradiol/Levonorgestrel) is commonly used to provide therapeutic benefit primarily in providing effective contraception and addressing symptoms related to systemic imbalance. This combination is applied across clinical settings that involve acute or disruptive symptom patterns related to the menstrual cycle.

It is generally used in situations involving irregular or absent periods, which supports a predictable cycle pattern, and assists with maintaining functional stability in daily life. This medication is commonly used to help ease symptoms related to physical discomfort, such as challenging cramping (dysmenorrhea), and to address symptoms that create noticeable physiological strain, such as heavy menstrual bleeding (menorrhagia). The application provides support that helps ease the overall symptom burden for indications including Polycystic Ovary Syndrome (PCOS), endometriosis-related pain, and hormonal acne.

“A key application is effective pregnancy prevention, but the medication also helps patients cope more steadily with symptom fluctuations tied to their cycle.”

Microstad is applied in contexts marked by increased discomfort related to hormonal manifestations, such as hormonal acne and Premenstrual Dysphoric Disorder (PMDD). It may assist with addressing symptoms that interfere with daily functioning, such as severe mood changes and certain skin-related issues.


Quick Fact: Relief for Heavy Bleeding The medication contributes to easing the overall symptom load and is used for managing menstrual blood loss in cases of menorrhagia, which may support the management of associated anemia.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Eligibility and Contraindications

Microstad (Ethinyl Estradiol/Levonorgestrel) is officially approved for use by females of reproductive potential for pregnancy prevention. However, government regulatory labeling establishes numerous absolute prohibitions and restrictions on use.


Absolute Contraindications

The medicine is contraindicated and must not be used by women over age 35 who smoke due to severely increased cardiovascular risk. Absolute non-eligibility also applies to those with a history of blood clots (VTE/PE), stroke, uncontrolled hypertension, liver tumors or severe liver disease, or breast cancer. Females experiencing migraine headaches with aura are also strictly prohibited from use.


Restricted Populations

Microstad is contraindicated during pregnancy and must be stopped immediately if pregnancy is confirmed. It is not recommended for nursing (lactating) mothers or for use in elderly (postmenopausal) women. Use is restricted around major surgery or prolonged immobilization, requiring discontinuation beforehand. The medication is not indicated for use before menarche.

What should I know about interactions with other medicines?

Microstad (Ethinyl Estradiol/Levonorgestrel) has officially documented interaction patterns primarily involving changes to the hormonal components' systemic exposure, as detailed in regulatory sources. Co-administered substances can either reduce or increase the concentration of the active ingredients.

Exposure-Altering Interactions

Substances known as Metabolic Enzyme Inducers (including certain anticonvulsants like Carbamazepine and the herbal product St. John's Wort) may significantly decrease the plasma levels of Microstad hormones. Conversely, strong CYP3A Inhibitors (such as specific antifungal agents like Itraconazole) may increase systemic exposure. The combination may also alter the levels of other co-administered medicines; for example, regulatory documentation states Microstad decreases the plasma concentration of Lamotrigine.

Interaction-Related Restrictions

Co-administration is formally contraindicated with specific Hepatitis C combination products (e.g., Ombitasvir/paritaprevir/ritonavir pm Dasabuvir), Oral Tranexamic Acid (due to pharmacodynamic risk), and Fezolinetant. The regulatory label also prohibits use in females over the age of 35 who smoke. To avoid interference with systemic exposure, Microstad must be administered four or more hours apart from Colesevelam, as required by the prescribing information. Interaction risks are also heightened in patients with hepatic impairment.

Mechanism of Action

How Microstad Works

Microstad's mechanism involves modulating activity within specific physiological pathways. The drug acts by influencing defined regulatory systems across central and peripheral contexts. Its action profile is determined by its ability to engage specific molecular machinery.


Targeted Receptor/Enzyme Modulation

Microstad initiates its action by selectively binding to and modulating specific receptor or enzyme systems. This engagement initiates or blocks precise signaling events, which defines the drug's activity and primary mechanistic focus.


Dampening Specific Signaling Cascades

The initial receptor/enzyme interaction modifies early molecular steps, allowing Microstad to operate within well-characterized molecular cascades. The intervention acts in pathways characterized by elevated signaling to reduce the intensity of signal transduction, thereby limiting the propagation of the signal.


Physiological Regulation

This influence on core mechanisms leads to specific alterations in physiological response patterns within targeted pathways. By affecting these signaling patterns, Microstad modifies the resulting physiological status and contributes to system-level modulation.

Dosage and Administration Information

How to Use Microstad

Microstad (Levonorgestrel/Ethinyl Estradiol) is administered orally and must be taken daily according to a strict, continuous schedule to maintain effectiveness. The usage protocol defines the routine, timing, and conditions of intake.


Administration Guidelines

Guideline Instruction
Route of Administration One tablet must be swallowed by mouth daily.
Standard Dosing Unit One tablet daily at the same time every day.
Regimen Structure Use involves following a cyclic or extended-cycle schedule (e.g., 21/7 or 84/7) in the order directed on the blister pack.

Procedural and Timing Rules

Administration must occur at intervals not exceeding 24 hours to achieve maximum systemic control. The initiation of the regimen follows one of two patterns:

  • Day 1 Start: The first tablet is taken on the first day of the menstrual period.
  • Sunday Start: The first tablet is taken on the first Sunday after the start of the menstrual period. An additional non-hormonal contraceptive method must be used for the first seven days of this starting regimen.

For females who are not breastfeeding, initiation should be no earlier than four weeks postpartum. The medication is not indicated for use in postmenopausal women.

If one active tablet is missed, it should be taken as soon as possible, even if this means taking two tablets in a single day, and then the regular schedule should be continued. If multiple active tablets are missed, specific procedures, including the use of back-up contraception, are required.

Recent Clinical Evidence

Research evidence / Overview of Studies for Microstad

Evidence for Use in Pregnancy Prevention (Contraception)

Research examined Microstad in the context of pregnancy prevention through large-scale epidemiological investigations and prospective cohort studies spanning decades. These high-level studies monitor how the medication was observed in vast populations of women of reproductive age. In controlled trials, the focus has been on short-term outcomes such as the inhibition of ovulation, which is an essential measure studied in contraceptive research.

Research describes that when the combination was observed in trials, consistent with protocols for "perfect use"—pregnancy rates were measured in the study populations. However, data show patterns related to a lower reported rate in typical use, which is understood to reflect the challenges of consistent daily adherence in real-world settings. Research describes potential limitations regarding the consistency of outcomes for individuals in groups with a higher Body Mass Index (BMI).


Evidence for Use in Managing Menstrual Symptoms

The combination hormone formulation research explored whether it was associated with outcomes for heavy menstrual bleeding (menorrhagia) and painful menstruation (dysmenorrhea). Randomized Controlled Trials (RCTs) in these areas typically focus on outcomes related to physical discomfort and outcomes reflecting daily functioning or activity level.

For heavy bleeding, research monitored patient-reported outcomes describing perceived discomfort and objective measurements of menstrual blood volume. Findings describe patterns observed in the studies where measurements of blood loss changed in the observed populations. Evidence remains limited regarding the long-term outcomes and durability of symptom patterns after the medication is stopped.


Evidence for Use in Other Specific Clinical Situations

Microstad was studied in research exploring short-term symptom changes in other contexts, including hormonal acne and certain symptoms associated with Polycystic Ovary Syndrome (PCOS).

For acne, studies explored outcomes linked to inflammatory or irritative states by monitoring changes in the count of total acne lesions. Research describes patterns where the measured outcome shifted during the study period. For PCOS-related symptoms, systematic reviews examined outcomes related to systemic or functional imbalance, reporting observations related to cycle regularity in study populations. However, data for certain groups remain insufficient, as research is primarily focused on short-term symptom patterns.

Key Studies & References Ethinyl Estradiol and Levonorgestrel: Drug Information

Frequently Asked Questions (FAQ)

Common questions about Microstad (FAQ)


Q: How quickly does Microstad typically start working?

A: Official administration instructions indicate that protection may not be immediate. For certain starting regimens, such as the Sunday Start, the official patient information recommends using a non-hormonal back-up method of birth control for the first seven days of use. The use of back-up contraception is recommended during the first week to support the regimen’s effectiveness.


Q: How long does Microstad stay in your system after you stop taking it?

A: Regulatory documents describe the half-life (the time it takes for half the drug to be eliminated) of the active ingredients as being approximately 24 hours. Official data indicates the components are largely eliminated from the system within a few days after the last dose, based on the documented half-life.


Q: Does Microstad interact with common pain relievers like ibuprofen?

A: Official drug interaction lists specify certain medicines that can affect the concentration of Microstad, such as strong metabolic enzyme inducers and inhibitors. However, common over-the-counter pain relievers like ibuprofen are typically not specifically listed or contraindicated in regulatory documents, indicating that no formal drug-drug interaction with Ibuprofen has been reported in the official prescribing information.


Q: Does Microstad cause weight gain or loss?

A: Official product information, according to regulatory documents, lists weight change (both gain and loss) as a possible side effect. Individual experience with side effects can vary. Users should refer to the 'Possible Side Effects' section for further details.


Q: Is it true that Microstad can affect liver function?

A: Official warnings state the medication is contraindicated (must not be used) in people with certain severe liver conditions, such as liver tumors or severe decompensated cirrhosis. The medication has also been associated with changes to liver function in some users, which is why official eligibility criteria are very specific regarding liver health.


Q: Are there any long-term health concerns associated with Microstad use?

A: Regulatory documents contain specific warnings regarding the risk of serious cardiovascular events, such as blood clots, stroke, and heart attack, particularly in women over 35 who smoke. They also discuss a potential increased risk of certain cancers, such as breast and liver tumors, associated with long-term use of this class of hormonal contraceptives.


Q: Is Microstad addictive or habit-forming?

A: Microstad is a combination of synthetic sex hormones and is not classified as a controlled substance by the DEA or FDA. Official drug classification information does not indicate this medication has abuse potential or is considered habit-forming.


Q: Why do doctors prescribe Microstad for condition X (if X is a known indication)?

A: The primary formal indication for Microstad, as stated in the official label, is the prevention of pregnancy. Some specific formulations containing these hormones have additional FDA-approved indications for conditions such as the treatment of moderate acne or management of premenstrual dysphoric disorder, which are stated in the detailed official drug label.


Q: Are there different strengths or versions of Microstad?

A: Yes, official regulatory documents state that Microstad (Ethinyl Estradiol and Levonorgestrel) is available in different dosing regimens and strengths of the active ingredients. The specific strength prescribed is based on the official labeling for the product.


Q: Do older adults (seniors) need to take a different dose of Microstad?

A: Official documents state that this medication is not indicated for use in postmenopausal women. The medication is not indicated for use in postmenopausal women, as clinical studies supporting its approved purpose were conducted in women of reproductive potential.


Q: Can Microstad be crushed or split if it's a tablet?

A: Official instructions specify that the tablets must be swallowed whole as formulated. The manufacturer does not provide instructions for splitting, crushing, or altering the tablet. The official guidance is to swallow tablets whole, as this is necessary to support the delivery of the correct dose.


Q: Is a metallic taste a known side effect of Microstad?

A: A metallic taste is not typically listed as a common or specific side effect in the official package insert. The most frequently reported gastrointestinal effects are nausea, vomiting, and abdominal cramping.


Q: Does taking Microstad require regular blood tests?

A: Regulatory documents recommend that healthcare providers monitor a user's blood pressure periodically and perform regular physical exams. However, official patient information does not typically mandate specific routine blood tests for all users of this medication.


Q: Does Microstad affect the ability to drive or operate machinery?

A: Official labels generally do not contain explicit warnings against driving or operating machinery. However, since common side effects include dizziness and headache, Official warnings suggest that individuals should observe how the medication affects them, particularly if they experience side effects like dizziness or headache.


Q: What is the general success rate mentioned in research for Microstad?

A: The effectiveness in clinical studies is measured by the Pearl Index, which is a statistical method for estimating the number of pregnancies that occur per 100 women using the method for one year. Official labeling specifies the typical efficacy rates for both 'perfect use' (following instructions exactly) and 'typical use' (real-world conditions).


Q: Does Microstad have any known interactions with herbal supplements?

A: The official drug interaction section specifically lists the herbal product St. John's Wort as a substance that can reduce the effectiveness of hormonal contraceptives. Official patient information stresses the importance of informing a healthcare professional about all supplements being used.


Q: Can Microstad cause skin rashes or sensitivity to the sun?

A: Official drug information lists skin rash as a potential side effect. The drug label mentions chloasma, a patchy discoloration of the skin. To help prevent chloasma from worsening, official information sometimes recommends avoiding sun exposure or using sunscreen.


Q: What is the 'black box warning' often discussed for medicines like Microstad?

A: The official FDA Boxed Warning for this class of medication states that cigarette smoking increases the risk of serious cardiovascular side effects from oral contraceptive use. This risk increases significantly with age, particularly in women over 35, and with the amount of smoking.


Q: What should be done if an allergic reaction is suspected with Microstad?

A: If signs of a serious allergic reaction, such as swelling of the face, tongue, or throat, are suspected, official patient information states that the user should immediately discontinue the medication and seek emergency medical attention.


Q: Does Microstad interact with birth control pills?

A: Microstad is a birth control pill (a Combined Oral Contraceptive). The use of other hormonal birth control methods, such as the patch, ring, implant, or other oral pills, is formally contraindicated and should not be combined with Microstad.


Q: Can I stop taking Microstad suddenly?

A: Official information states that consultation with a healthcare professional is necessary before stopping the medication. Stopping suddenly will result in a loss of pregnancy protection and may also lead to changes in the menstrual cycle pattern.


Q: Does Microstad affect mood or mental health?

A: Official drug information lists mood changes and mental depression as potential side effects of the medication. The official product information notes that users should be aware of these potential changes.


Q: Is Microstad a scheduled drug (controlled substance)?

A: Microstad (Ethinyl Estradiol and Levonorgestrel) is a combination hormonal contraceptive and is not listed as a controlled substance by the DEA or other regulatory bodies.


Q: Does Microstad need to be taken with food or on an empty stomach?

A: Official patient information often advises that the tablets may be taken with or without food. Official patient information notes that taking the tablet with food or at bedtime may help in reducing the common side effect of nausea.

How should Microstad be stored and disposed of?

Official Storage and Disposal Requirements

Microstad (Ethinyl Estradiol and Levonorgestrel) must be stored strictly according to regulatory guidelines to ensure product stability and efficacy.

Storage Condition Requirement
Temperature Store at controlled room temperature (20°C to 25°C or 68°F to 77°F).
Environmental Keep away from heat, moisture, direct light, and do not freeze.
Container Keep in its original, tightly closed container until use.

The official labeling mandates that the medicine must be kept out of the reach and sight of children. Do not keep outdated or unused medicine. For proper disposal, users are instructed to consult a pharmacist or healthcare professional for guidance on discarding the unused product, thereby preventing accidental ingestion or environmental release.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Microstad found in:

A-Z Index: